마이크로 봉합사 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 수술별, 용도별, 소재별, 지역별 및 부문별 예측(2026-2033년)

Microsutures Market Summary

The global microsutures market size was estimated at USD 329.07 million in 2025 and is projected to reach USD 431.44 million by 2033, growing at a CAGR of 3.45% from 2026 to 2033. This market growth is largely attributed to advancements in minimally invasive surgical techniques, the increasing prevalence of chronic diseases requiring precise wound management, and the growth of medical tourism.

The growing demand for cosmetic and reconstructive surgeries further drives the adoption of microsutures, as they enable fine, less noticeable stitches, resulting in better aesthetic outcomes. In addition, technological innovations in suture materials, such as biodegradable and high-strength sutures, enhance the efficiency and safety of procedures, encouraging their widespread use.

The growing number of surgical procedures, mainly cosmetic and plastic surgeries, has fueled the demand in the microsutures industry. For instance, according to the Global Survey 2024, Eyelid surgery is for the first time the most common surgical procedure in 2024, replacing liposuction, followed by breast augmentation, scar revision, and rhinoplasty. The most popular non-surgical procedures were botulinum toxin, hyaluronic acid (filler), hair removal, non-surgical skin tightening, and chemical peels. These increased procedures directly affect the demand for sutures, which play a significant role in wound closure and post-surgery recovery.Beyond cosmetic surgeries, demand for sutures is also driven by essential medical procedures such as cesarean sections, orthopedic surgeries, and cardiovascular interventions, further expanding the market's growth potential.

Global Microsutures Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global microsutures market report based on product, surgery, end use, material, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Absorbable
• Non-absorbable
• Surgery Outlook (Revenue, USD Million, 2021 - 2033)
• General Surgery
• Ophthalmology
• Plastic and Reconstructive Surgery
• Neurosurgery
• Cardiovascular Surgery
• Transplantation
• Gynecological Surgery
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Center (ASC)
• Specialty Clinics
  • Ophthalmic and Eye Surgery Clinics
  • Plastic and Reconstructive Surgery Clinics
  • Fertility Clinics
  • Dental Clinics
• Others
• Material Outlook (Revenue, USD Million, 2021 - 2033)
• Nylon
• Polyglycolic Acid (PGA)
• Polydioxanone
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Third Party Perspective
  • 1.3.5. Primary research
  • 1.3.6. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights Outlook

Chapter 3. Microsutures Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Related/ancillary market outlook.
• 3.2. User Perspective Analysis
  • 3.2.1. Consumer behavior analysis
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Increasing volume of microsurgical and minimally invasive procedures
    • 3.3.1.2. Rising prevalence of chronic diseases
    • 3.3.1.3. Growing demand for cosmetic and reconstructive surgeries requiring precision wound closure
    • 3.3.1.4. Advancements in biocompatible, absorbable, and antimicrobial suture materials
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. High cost of advanced microsutures and associated surgical procedures
    • 3.3.2.2. Requirement of highly skilled surgeons and specialized training
    • 3.3.2.3. Growing adoption of alternative wound closure methods (adhesives, staplers)
  • 3.3.3. Market opportunity analysis
    • 3.3.3.1. Expansion of healthcare infrastructure in emerging economies
    • 3.3.3.2. Rising awareness of early diagnosis and surgical treatment
    • 3.3.3.3. Development of antimicrobial-coated and drug-eluting microsutures
  • 3.3.4. Market challenge analysis
    • 3.3.4.1. Technical complexity in manufacturing ultra-fine, high-strength sutures
    • 3.3.4.2. Stringent regulatory approvals and compliance requirements
• 3.4. Microsutures Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Microsutures Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
• 4.2. Product Market Share, 2021 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Microsutures Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
  • 4.5.1. Absorbable
    • 4.5.1.1. Absorbable market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5.2. Non-Absorbable
    • 4.5.2.1. Non-absorbable market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Microsutures Market: Surgery Estimates & Trend Analysis

• 5.1. Definitions and Scope
• 5.2. Surgery Market Share, 2021 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Microsutures Market by Surgery Use Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
  • 5.5.1. General Surgery
    • 5.5.1.1. General Surgery market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.2. Ophthalmology
    • 5.5.2.1. Ophthalmology market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.3. Plastic and reconstructive surgery
    • 5.5.3.1. Plastic and reconstructive surgery market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.4. Neurosurgery
    • 5.5.4.1. Neurosurgery market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.5. Cardiovascular surgery
    • 5.5.5.1. Cardiovascular surgery market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.6. Transplantation
    • 5.5.6.1. Transplantation market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.7. Gynecological Surgery
    • 5.5.7.1. Gynecological Surgery market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.8. Others
    • 5.5.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Microsutures Market: Material Estimates & Trend Analysis

• 6.1. Definitions and Scope
• 6.2. Material Market Share, 2021 & 2033
• 6.3. Segment Dashboard
• 6.4. Global Microsutures Market by Material Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
  • 6.5.1. Nylon
    • 6.5.1.1. Nylon market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.2. Polyglycolic Acid (PGA)
    • 6.5.2.1. Polyglycolic Acid (PGA) market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.3. Polydioxanone
    • 6.5.3.1. Polydioxanone market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.4. Others
    • 6.5.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Microsutures Market: End Use Estimates & Trend Analysis

• 7.1. Definitions and Scope
• 7.2. End Use Market Share, 2021 & 2033
• 7.3. Segment Dashboard
• 7.4. Global Microsutures Market by End Use Outlook
• 7.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
  • 7.5.1. Hospitals
    • 7.5.1.1. Hospitals market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.2. Ambulatory Surgery Center (ASC)
    • 7.5.2.1. Ambulatory Surgery Center (ASC) market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.3. Specialty Clinics
    • 7.5.3.1. Specialty clinics market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3.2. Ophthalmic and Eye Surgery Clinics
      • 7.5.3.2.1. Ophthalmic and eye surgery clinics market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3.3. Fertility Clinics
      • 7.5.3.3.1. Fertility clinics market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3.4. Plastic and Reconstructive Surgery Clinics
      • 7.5.3.4.1. Plastic and reconstructive surgery clinics market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3.5. Dental Clinics
      • 7.5.3.5.1. Dental clinics market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.4. Others
    • 7.5.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Microsutures Market: Regional Estimates & Trend Analysis by Product, Surgery, Material, End Use

• 8.1. Regional market share analysis, 2025 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Regional Market Share and Leading Players, 2025
  • 8.4.1. North America
  • 8.4.2. Europe
  • 8.4.3. Asia Pacific
  • 8.4.4. Latin America
  • 8.4.5. Middle East and Africa
• 8.5. Market Modality, & Forecasts and Trend Analysis, 2021 to 2033
• 8.6. North America
  • 8.6.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 8.6.2. U.S.
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 8.6.3. Canada
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Reimbursement scenario
    • 8.6.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 8.6.4. Mexico
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. Reimbursement scenario
    • 8.6.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 8.7. Europe
  • 8.7.1. Germany
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement scenario
    • 8.7.1.5. Germany market estimates and forecasts, 2021 - 2033
  • 8.7.2. UK
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. UK market estimates and forecasts, 2021 - 2033
  • 8.7.3. France
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. France market estimates and forecasts, 2021 - 2033
  • 8.7.4. Italy
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement scenario
    • 8.7.4.5. Italy market estimates and forecasts, 2021 - 2033
  • 8.7.5. Spain
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Reimbursement scenario
    • 8.7.5.5. Spain market estimates and forecasts, 2021 - 2033
  • 8.7.6. Denmark
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Competitive scenario
    • 8.7.6.3. Regulatory framework
    • 8.7.6.4. Reimbursement scenario
    • 8.7.6.5. Denmark market estimates and forecasts, 2021 - 2033
  • 8.7.7. Sweden
    • 8.7.7.1. Key country dynamics
    • 8.7.7.2. Competitive scenario
    • 8.7.7.3. Regulatory framework
    • 8.7.7.4. Reimbursement scenario
    • 8.7.7.5. Sweden market estimates and forecasts, 2021 - 2033
  • 8.7.8. Norway
    • 8.7.8.1. Key country dynamics
    • 8.7.8.2. Competitive scenario
    • 8.7.8.3. Regulatory framework
    • 8.7.8.4. Reimbursement scenario
    • 8.7.8.5. Norway market estimates and forecasts, 2021 - 2033
  • 8.7.9. Netherlands
    • 8.7.9.1. Key country dynamics
    • 8.7.9.2. Competitive scenario
    • 8.7.9.3. Regulatory framework
    • 8.7.9.4. Reimbursement scenario
    • 8.7.9.5. Netherlands market estimates and forecasts, 2021 - 2033
• 8.8. Asia Pacific
  • 8.8.1. China
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Competitive scenario
    • 8.8.1.3. Regulatory framework
    • 8.8.1.4. Reimbursement scenario
    • 8.8.1.5. China market estimates and forecasts, 2021 - 2033
  • 8.8.2. Japan
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. Reimbursement scenario
    • 8.8.2.5. Japan market estimates and forecasts, 2021 - 2033
  • 8.8.3. India
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Competitive scenario
    • 8.8.3.3. Regulatory framework
    • 8.8.3.4. Reimbursement scenario
    • 8.8.3.5. India market estimates and forecasts, 2021 - 2033
  • 8.8.4. Australia
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Competitive scenario
    • 8.8.4.3. Regulatory framework
    • 8.8.4.4. Reimbursement scenario
    • 8.8.4.5. Australia market estimates and forecasts, 2021 - 2033
  • 8.8.5. South Korea
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Competitive scenario
    • 8.8.5.3. Regulatory framework
    • 8.8.5.4. Reimbursement scenario
    • 8.8.5.5. South Korea market estimates and forecasts, 2021 - 2033
  • 8.8.6. Thailand
    • 8.8.6.1. Key country dynamics
    • 8.8.6.2. Competitive scenario
    • 8.8.6.3. Regulatory framework
    • 8.8.6.4. Reimbursement scenario
    • 8.8.6.5. Thailand market estimates and forecasts, 2021 - 2033
• 8.9. Latin America
  • 8.9.1. Brazil
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Competitive scenario
    • 8.9.1.3. Regulatory framework
    • 8.9.1.4. Reimbursement scenario
    • 8.9.1.5. Brazil market estimates and forecasts, 2021 - 2033
  • 8.9.2. Argentina
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Competitive scenario
    • 8.9.2.3. Regulatory framework
    • 8.9.2.4. Reimbursement scenario
    • 8.9.2.5. Argentina market estimates and forecasts, 2021 - 2033
• 8.10. MEA
  • 8.10.1. South Africa
    • 8.10.1.1. Key country dynamics
    • 8.10.1.2. Competitive scenario
    • 8.10.1.3. Regulatory framework
    • 8.10.1.4. Reimbursement scenario
    • 8.10.1.5. South Africa market estimates and forecasts, 2021 - 2033
  • 8.10.2. Saudi Arabia
    • 8.10.2.1. Key country dynamics
    • 8.10.2.2. Competitive scenario
    • 8.10.2.3. Regulatory framework
    • 8.10.2.4. Reimbursement scenario
    • 8.10.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 8.10.3. UAE
    • 8.10.3.1. Key country dynamics
    • 8.10.3.2. Competitive scenario
    • 8.10.3.3. Regulatory framework
    • 8.10.3.4. Reimbursement scenario
    • 8.10.3.5. UAE market estimates and forecasts, 2021 - 2033
  • 8.10.4. Kuwait
    • 8.10.4.1. Key country dynamics
    • 8.10.4.2. Competitive scenario
    • 8.10.4.3. Regulatory framework
    • 8.10.4.4. Reimbursement scenario
    • 8.10.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
  • 9.2.1. Innovators
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2025
  • 9.3.4. Corza Medical
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Baxter
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. AD Surgical
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Ethicon (Johnson & Johnson)
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Kono Seisakusho Group
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Suturex
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. AROSurgical Instruments
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Bear Medic Corporation
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Altomed
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. Unisur Lifecare
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives